In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Merck & Company (MRK – Research Report). The ...

Robert Kennedy Jr. will keep his share of any windfall from litigation against Merck (MRK) even if he becomes Donald Trump’s top U.S. health ...

Robert F. Kennedy Jr., President Donald Trump‘s nominee for Health and Human Services Secretary, is facing scrutiny over his decision to retain financial interests in ongoing litigation against Merck ...

The CEO of Germany's Merck KGaA said a recovery in sales growth at its existing business means it can take a cautious ...

AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the company’s future looks bright.

House Ag Committee Chair Glenn "GT" Thompson speaks to the crowd in a Holstein print bowtie at the ag inaugural ball Jan. 20 The House Agriculture Committee on Thursday released its subcommittee ...

Financial writer analysis of Arcutis Biotherapeutics, Inc. stock surge and potential growth, FDA approvals, and partnerships in 2025. Click for this ARQT update.

In this piece, we will look at the stocks Jim Cramer recently discussed.

Investors love dividend stocks, especially the high-yield mega-cap variety, because they offer a significant income stream ...